From 3 Meetings to 1: Remove Bottlenecks with AI-Enabled eCOA

Tired of delays, white space, and endless meetings slowing your studies? Join this demo webinar to see how AI-enabled eCOA is already helping sponsors cut build time from weeks to a single day, accelerate translations by 75%, and win back 6 weeks per trial. Smarter, faster, proven—see it live!

Register Free: https://www.biopharminternational.com/bp_w/bottlenecks

Event Overview:

If you lead clinical operations, you don’t need to be told about trial bottlenecks and delays—you live them.

Eliminating this white space (the dead time) in study management means addressing multiple challenges head-on. These obstacles include the endless oversight meetings, translation complexities, back-and-forth waiting for testing and approvals, slow manual eCOA builds, and the constant waits for data readiness that add weeks, sometimes months, to timelines you’re already under pressure to accelerate.

This webinar, featuring a product demo, will showcase how AI-enabled eCOA is easing those burdens today. Live in numerous studies, this technology already helps top pharma sponsors and CROs consolidate three meetings into just one, achieve 35X faster first-time eCOA creation, and gain back 4–6 weeks to focus on science and patients.

Fewer meetings, faster data, smarter trials. Register for this session now to support your 2026 planning!

Key Learning Objectives:

• Kick-off Faster: Eliminate redundant meetings and start trials sooner.
• Build in a Day: Cut eCOA setup from 1–2 weeks to 1 day.
• Accelerate Translation Turnaround: From 12–16 days to just 4, with 25% cost savings.

Who Should Attend:

• Professionals in small/medium/large pharma and biotech
• Professionals in clinical operations, research, and development
• Professionals working in CROs
• eCOA/ePRO leads
• AI leaders
• Therapeutic area leads
• Professionals in safety and growth
• Professionals in data management, processing, analysis, science, and collection
• Professionals in trial innovation, management, and trial optimization
• Professionals in digital innovation, decentralized trials, and clinical innovation
• Professionals in digital endpoints and digital health
• Those working with real-world data and evidence
• Professionals in clinical IT and clinical systems
• Those in charge of patient outcomes and solutions

Speakers:

Alison Holland
Chief Customer Officer
Medable

Alison Holland’s expertise in fostering strong relationships and her strategic vision have been vital in advancing Medable’s mission to get effective therapies to patients faster. During her six-year tenure at Medable, she has been instrumental in the development and deployment of the company’s eCOA+, Total Consent, and TA workflow offerings, which have all contributed to reducing study timelines by up to 50% for customers.

Prior to joining Medable, Holland gained extensive clinical development know-how from two decades at a global CRO leading various R&D divisions, including the Infectious Disease, Inflammation, and General Medicine business unit. Her experience in managing all key milestones of clinical programs, from initial protocol design to database-lock, has been invaluable in progressing digital trial technologies across the life sciences industry.

Asad Khan
Senior Director, Customer Success Lead
Medable

Asad Khan has over 15 years of project and customer relationship management experience in the design, implementation, and deployment of eClinical (ePRO, eClinRO, CTMS, RBM, Data Analytics, and DCT) and SaaS solutions. He holds a proven track record of working with global clinical teams, being a key driver in system adoption and training, and delivering complex studies in short timelines—receiving excellent client feedback. Khan is certified in Good Clinical Practice (GCP) and has advanced knowledge of FDA and EMEA regulations for pharmaceuticals and medical devices.

Register Free: https://www.biopharminternational.com/bp_w/bottlenecks